Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Zola Global Investors

Investor type Family Investment Office


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 12
Average round size
The average size of a deal this fund participated in
Portfolio companies 9
Lead investments 3
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees Soon

Areas of investment

  • Health Care
  • Medical
  • Blockchain
  • E-Commerce
  • Consumer

The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in 2-6 investment rounds annually. The important activity for fund was in 2019.

The standard case for the fund is to invest in rounds with 5-6 partakers. The meaningful sponsors for the fund in investment in the same round are Viking Global Investors, Uji Capital, Toba Capital.

Among the most popular portfolio startups of the fund, we may highlight High 12 Brands, DermBiont. Among the most popular fund investment industries, there are Creative Agency, Consumer Research. Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Zola Global Investors:
Typical Co-investors
Zola Global Investors is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Zola Global Investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AquaSpark Center District, Israel, Rishon Lezion
Beijing Lanpu Capital Management Beijing, Beijing, China
Benhamou Global Ventures California, Palo Alto, United States
Erste Oetker Beteiligungs -
First Light Asset Management Hennepin, Illinois, United States
Harrington Family Hudson, Ohio, United States
Mirae Asset-Naver Asia Growth Fund -
Siemens Bank Bayern, Germany, Muenchen
Tribune Capital Canada, Saskatchewan, Weyburn
Ulead Systems -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Information Technology
Open Source
$26M17 Nov 2021 Los Angeles, California, United States


$23M20 Oct 2021 San Francisco, California, United States


Web Design
$20M01 Sep 2021 San Francisco, California, United States

Artificial Intelligence
Clinical Trials
Computer Vision
Data Visualization
Health Care
Life Science
Machine Learning
$18M07 Jun 2021 San Jose, California, United States

Peer to Peer
$5M13 Apr 2021 Zug, Switzerland

HALO Diagnostics

Health Care
Health Diagnostics
Medical Device
$19M04 Mar 2021 California, United States

Alto Pharmacy

Health Care
$250M30 Jan 2020 San Francisco, California, United States

High 12 Brands

Consumer Research
Creative Agency
Product Search
$5M04 Oct 2019 Ontario


Health Care
$8M18 Jun 2019 Boston, Massachusetts, United States
Clinical AI Technology Leader Mendel Raises $18M in New Capital

– Mendel, the company behind the clinical AI platform that understands the unstructured, natural language content within medical documents, announced it has raised $18 million in Series A funding.
– The oversubscribed round was led by DCM, a global venture capital firm, with participation from OliveTree, Zola Global Investors and Millennium Technology Value Partners.
– Return investors include Launch Capital, SOSV, Bootstrap Labs and Chairman of UCSF Health Hub Mark Goldstein.
– Olive Tree Managing Partner, Nichola Eliovits, will join the board.
– The capital will help the company rapidly grow its business and sales team to keep up with the explosive demand for clinical AI technologies by healthcare organizations over the last year.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Zola Global Investors?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: